Cermaq suffering from impacts of disease

Details
Promoted
Alert sent: 
Yes
Sites: 
AH
Channel: 
Pests/diseases
Text (summary): 
CERMAQ has reported an EBIT pre fair value and biomass write-down for this year's Q3 of NOK 232 million. Solid results in EWOS, particularly due to high volume and capacity utilisation in Norway, compensated for low salmon prices and biological challenges in Mainstream.
Third quarter 2012 EBIT pre fair value and biomass write-down was NOK 232 million compared to NOK 348 million for third quarter 2011. Following write-downs in Canada due to the IHN virus outbreak and in Norway from the PD outbreak, EBIT pre fair value for the quarter was NOK 180 million.
"This is in total a sati
Tags
Locations
LocationCoordinatesZoomRelevanceShow on map
Norway
60.472°N 8.46895°E
1
0.500
Yes
Discovery
Discoveries: 
Discovery method: 
Robot discovered
Discovery time: 
Tue 2012-Oct-23 16:00
URL: 
Original language: 
Original title: 
Cermaq suffering from impacts of disease
Original text (summary): 

CERMAQ has reported an EBIT pre fair value and biomass write-down for this year's Q3 of NOK 232 million. Solid results in EWOS, particularly due to high volume and capacity utilisation in Norway, compensated for low salmon prices and biological challenges in Mainstream.

Third quarter 2012 EBIT pre fair value and biomass write-down was NOK 232 million compared to NOK 348 million for third quarter 2011. Following write-downs in Canada due to the IHN virus outbreak and in Norway from the PD outbreak, EBIT pre fair value for the quarter was NOK 180 million.

"This is in total a satisfactory result based on the current challenging salmon market, says CEO Jon Hindar. "The underlying operational farming cost has been stable with a reduction in Mainstream Norway, which previously was communicated and expected. EWOS is at the same time demonstrating its capability of optimising the production capacity in a peak production period."